ReP USP - Resultado da busca

Artigo de periodico
T-cell recognition of Paracoccidioides brasiliensis gp43-derived peptides in patients with paracoccidioidomycosis and healthy individuals (2007)
Iwai, Leo Kei; Yoshida, Márcia; Sadahiro, Aya; Silva, Washington Robert da; Marin, Maria Lucia; Goldberg, Anna Carla; Juliano, Maria Aparecida; Juliano, Luiz; Shikanai Yasuda, Maria Aparecida; Kalil Filho, Jorge Elias; Cunha Neto, Edecio; Travassos, Luiz Rodolpho
Source: Clinical and Vaccine Immunology. Unidades: IQ, FM
Subjects: PARACOCCIDIOIDES BRASILIENSIS, PEPTÍDEOS, ANTÍGENOS DE FUNGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
IWAI, Leo Kei et al. T-cell recognition of Paracoccidioides brasiliensis gp43-derived peptides in patients with paracoccidioidomycosis and healthy individuals. Clinical and Vaccine Immunology, v. 14, n. 4, p. 474-476, 2007Tradução . . Acesso em: 02 maio 2024.
APA
Iwai, L. K., Yoshida, M., Sadahiro, A., Silva, W. R. da, Marin, M. L., Goldberg, A. C., et al. (2007). T-cell recognition of Paracoccidioides brasiliensis gp43-derived peptides in patients with paracoccidioidomycosis and healthy individuals. Clinical and Vaccine Immunology, 14( 4), 474-476.
NLM
Iwai LK, Yoshida M, Sadahiro A, Silva WR da, Marin ML, Goldberg AC, Juliano MA, Juliano L, Shikanai Yasuda MA, Kalil Filho JE, Cunha Neto E, Travassos LR. T-cell recognition of Paracoccidioides brasiliensis gp43-derived peptides in patients with paracoccidioidomycosis and healthy individuals. Clinical and Vaccine Immunology. 2007 ; 14( 4): 474-476.[citado 2024 maio 02 ]
Vancouver
Iwai LK, Yoshida M, Sadahiro A, Silva WR da, Marin ML, Goldberg AC, Juliano MA, Juliano L, Shikanai Yasuda MA, Kalil Filho JE, Cunha Neto E, Travassos LR. T-cell recognition of Paracoccidioides brasiliensis gp43-derived peptides in patients with paracoccidioidomycosis and healthy individuals. Clinical and Vaccine Immunology. 2007 ; 14( 4): 474-476.[citado 2024 maio 02 ]
Artigo de periodico
T-Cell Recognition of Paracoccidioides brasiliensis gp43-Derived Peptides in Patients with Paracoccidioidomycosis and Healthy Individuals (2007)
Iwai, Leo Kei; Yoshida, Márcia; Sadahiro, Aya; Silva, Washington Robert da; Marin, Maria Lucia; Goldberg, Anna Carla; Juliano, Maria Aparecida; Juliano, Luiz; Shikanai-Yasuda, Maria Aparecida; Kalil, Jorge; Cunha-Neto, Edecio; Travassos, Luiz R.
Source: Clinical and Vaccine Immunology. Unidade: FM
Subjects: PARACOCCIDIOIDOMICOSE, PARACOCCIDIOIDES, LINFÓCITOS T (IMUNOLOGIA), VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
IWAI, Leo Kei et al. T-Cell Recognition of Paracoccidioides brasiliensis gp43-Derived Peptides in Patients with Paracoccidioidomycosis and Healthy Individuals. Clinical and Vaccine Immunology, v. 14, n. 4, p. 474-476, 2007Tradução . . Disponível em: https://doi.org/10.1128/CVI.00458-06. Acesso em: 02 maio 2024.
APA
Iwai, L. K., Yoshida, M., Sadahiro, A., Silva, W. R. da, Marin, M. L., Goldberg, A. C., et al. (2007). T-Cell Recognition of Paracoccidioides brasiliensis gp43-Derived Peptides in Patients with Paracoccidioidomycosis and Healthy Individuals. Clinical and Vaccine Immunology, 14( 4), 474-476. doi:10.1128/CVI.00458-06
NLM
Iwai LK, Yoshida M, Sadahiro A, Silva WR da, Marin ML, Goldberg AC, Juliano MA, Juliano L, Shikanai-Yasuda MA, Kalil J, Cunha-Neto E, Travassos LR. T-Cell Recognition of Paracoccidioides brasiliensis gp43-Derived Peptides in Patients with Paracoccidioidomycosis and Healthy Individuals [Internet]. Clinical and Vaccine Immunology. 2007 ; 14( 4): 474-476.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/CVI.00458-06
Vancouver
Iwai LK, Yoshida M, Sadahiro A, Silva WR da, Marin ML, Goldberg AC, Juliano MA, Juliano L, Shikanai-Yasuda MA, Kalil J, Cunha-Neto E, Travassos LR. T-Cell Recognition of Paracoccidioides brasiliensis gp43-Derived Peptides in Patients with Paracoccidioidomycosis and Healthy Individuals [Internet]. Clinical and Vaccine Immunology. 2007 ; 14( 4): 474-476.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/CVI.00458-06
Artigo de periodico
Serodiagnosis as Adjunct Assay for Pertussis Infection in Sao Paulo, Brazil (2014)
Vaz de Lima, L R A; Ana Freitas Ribeiro; Carvalhanas, T. R. M. T; Nakasaki, R. M. D; Oliveira, Silva S; Waldman, Eliseu Alves; Tondella, M. L; Martin, M. D; Pawloski, L. C; Leite, D; Rocha, K. C. P; Brito, C. A de; Vaz, T. M. I; Martins, L. Moura; Alvarenga, D. P
Source: Clinical and Vaccine Immunology. Unidade: FSP
Subjects: COQUELUCHE, TESTES SOROLÓGICOS, IMUNIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VAZ DE LIMA, L R A et al. Serodiagnosis as Adjunct Assay for Pertussis Infection in Sao Paulo, Brazil. Clinical and Vaccine Immunology, v. 21, n. , p. CVI.00760-13-640, 2014Tradução . . Disponível em: https://doi.org/10.1128/cvi.00760-13. Acesso em: 02 maio 2024.
APA
Vaz de Lima, L. R. A., Ana Freitas Ribeiro,, Carvalhanas, T. R. M. T., Nakasaki, R. M. D., Oliveira, S. S., Waldman, E. A., et al. (2014). Serodiagnosis as Adjunct Assay for Pertussis Infection in Sao Paulo, Brazil. Clinical and Vaccine Immunology, 21( ), CVI.00760-13-640. doi:10.1128/cvi.00760-13
NLM
Vaz de Lima LRA, Ana Freitas Ribeiro, Carvalhanas TRMT, Nakasaki RMD, Oliveira SS, Waldman EA, Tondella ML, Martin MD, Pawloski LC, Leite D, Rocha KCP, Brito CA de, Vaz TMI, Martins LM, Alvarenga DP. Serodiagnosis as Adjunct Assay for Pertussis Infection in Sao Paulo, Brazil [Internet]. Clinical and Vaccine Immunology. 2014 ;21( ): CVI.00760-13-640.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/cvi.00760-13
Vancouver
Vaz de Lima LRA, Ana Freitas Ribeiro, Carvalhanas TRMT, Nakasaki RMD, Oliveira SS, Waldman EA, Tondella ML, Martin MD, Pawloski LC, Leite D, Rocha KCP, Brito CA de, Vaz TMI, Martins LM, Alvarenga DP. Serodiagnosis as Adjunct Assay for Pertussis Infection in Sao Paulo, Brazil [Internet]. Clinical and Vaccine Immunology. 2014 ;21( ): CVI.00760-13-640.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/cvi.00760-13
Artigo de periodico
Salmonella enterica serovar typhimurium vaccine strains expressing a nontoxic shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli (2010)
Rojas, Robert Leonardo Galvez; Gomes, Priscila Aparecida Dal Pozo; Bentancor, Letícia V.; Sbrogio-Almeida, Maria E.; Costa, Sergio Olavo Pinto da; Massis, Liliana Moura; Ferreira, Rita de Cássia Café ; Palermo, Marina S.; Ferreira, Luís Carlos de Souza
Source: Clinical and Vaccine Immunology. Unidades: IB, ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROJAS, Robert Leonardo Galvez et al. Salmonella enterica serovar typhimurium vaccine strains expressing a nontoxic shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli. Clinical and Vaccine Immunology, v. 17, n. 4, p. 529-36, 2010Tradução . . Acesso em: 02 maio 2024.
APA
Rojas, R. L. G., Gomes, P. A. D. P., Bentancor, L. V., Sbrogio-Almeida, M. E., Costa, S. O. P. da, Massis, L. M., et al. (2010). Salmonella enterica serovar typhimurium vaccine strains expressing a nontoxic shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli. Clinical and Vaccine Immunology, 17( 4), 529-36.
NLM
Rojas RLG, Gomes PADP, Bentancor LV, Sbrogio-Almeida ME, Costa SOP da, Massis LM, Ferreira R de CC, Palermo MS, Ferreira LC de S. Salmonella enterica serovar typhimurium vaccine strains expressing a nontoxic shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli. Clinical and Vaccine Immunology. 2010 ; 17( 4): 529-36.[citado 2024 maio 02 ]
Vancouver
Rojas RLG, Gomes PADP, Bentancor LV, Sbrogio-Almeida ME, Costa SOP da, Massis LM, Ferreira R de CC, Palermo MS, Ferreira LC de S. Salmonella enterica serovar typhimurium vaccine strains expressing a nontoxic shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli. Clinical and Vaccine Immunology. 2010 ; 17( 4): 529-36.[citado 2024 maio 02 ]
Artigo de periodico
Quality assurance program for peripheral blood mononuclear cell cryopreservation (2007)
Weinberg, Adriana; Louzão, Raul; Mussi-Pinhata, Marisa Márcia; Cruz, Maria L. S.; Pinto, Jorge A.; Huff, Maria F.; Castro, Andrea C. de; Sucupira, Maria C.; Denny, Thomas N.
Source: Clinical and Vaccine Immunology. Unidade: FMRP
Subjects: CRIOPRESERVAÇÃO, CÉLULAS SANGUÍNEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WEINBERG, Adriana et al. Quality assurance program for peripheral blood mononuclear cell cryopreservation. Clinical and Vaccine Immunology, v. 15, n. 9, p. 1242-1244, 2007Tradução . . Acesso em: 02 maio 2024.
APA
Weinberg, A., Louzão, R., Mussi-Pinhata, M. M., Cruz, M. L. S., Pinto, J. A., Huff, M. F., et al. (2007). Quality assurance program for peripheral blood mononuclear cell cryopreservation. Clinical and Vaccine Immunology, 15( 9), 1242-1244.
NLM
Weinberg A, Louzão R, Mussi-Pinhata MM, Cruz MLS, Pinto JA, Huff MF, Castro AC de, Sucupira MC, Denny TN. Quality assurance program for peripheral blood mononuclear cell cryopreservation. Clinical and Vaccine Immunology. 2007 ; 15( 9): 1242-1244.[citado 2024 maio 02 ]
Vancouver
Weinberg A, Louzão R, Mussi-Pinhata MM, Cruz MLS, Pinto JA, Huff MF, Castro AC de, Sucupira MC, Denny TN. Quality assurance program for peripheral blood mononuclear cell cryopreservation. Clinical and Vaccine Immunology. 2007 ; 15( 9): 1242-1244.[citado 2024 maio 02 ]
Artigo de periodico
Protective immunity and reduced renal colonization induced by vaccines containing recombinant Leptospira interrogans outer membrane proteins and flagellin adjuvant (2015)
Monaris, Denize; Sbrogio-Almeida, Maria Elisabete; Dib, Cristina Corsi; Canhamero, T. A; Souza, G. O; Vasconcellos, Silvio Arruda; Ferreira, Luís Carlos de Souza ; Abreu, Patricia Antonia Estima
Source: Clinical and Vaccine Immunology. Unidades: FMVZ, ICB
Subjects: LEPTOSPIROSE, LEPTOSPIROSE ANIMAL, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONARIS, Denize et al. Protective immunity and reduced renal colonization induced by vaccines containing recombinant Leptospira interrogans outer membrane proteins and flagellin adjuvant. Clinical and Vaccine Immunology, v. 22, n. 8, p. 965-973, 2015Tradução . . Disponível em: https://doi.org/10.1128/CVI.00285-15. Acesso em: 02 maio 2024.
APA
Monaris, D., Sbrogio-Almeida, M. E., Dib, C. C., Canhamero, T. A., Souza, G. O., Vasconcellos, S. A., et al. (2015). Protective immunity and reduced renal colonization induced by vaccines containing recombinant Leptospira interrogans outer membrane proteins and flagellin adjuvant. Clinical and Vaccine Immunology, 22( 8), 965-973. doi:10.1128/CVI.00285-15
NLM
Monaris D, Sbrogio-Almeida ME, Dib CC, Canhamero TA, Souza GO, Vasconcellos SA, Ferreira LC de S, Abreu PAE. Protective immunity and reduced renal colonization induced by vaccines containing recombinant Leptospira interrogans outer membrane proteins and flagellin adjuvant [Internet]. Clinical and Vaccine Immunology. 2015 ; 22( 8): 965-973.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/CVI.00285-15
Vancouver
Monaris D, Sbrogio-Almeida ME, Dib CC, Canhamero TA, Souza GO, Vasconcellos SA, Ferreira LC de S, Abreu PAE. Protective immunity and reduced renal colonization induced by vaccines containing recombinant Leptospira interrogans outer membrane proteins and flagellin adjuvant [Internet]. Clinical and Vaccine Immunology. 2015 ; 22( 8): 965-973.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/CVI.00285-15
Artigo de periodico
Prophylactic and therapeutic vaccination using dendritic cells primed with peptide 10 derived from the 43-kilodalton glycoprotein of Paracoccidioides brasiliensis (2012)
Magalhães, A; Ferreira, K. S; Almeida, Sandro Rogério de ; Nosanchuk, J. D; Travassos, L. R; Taborda, Carlos Pelleschi
Source: Clinical and Vaccine Immunology. Unidades: FCF, ICB
Subjects: ANTÍGENOS, MACRÓFAGOS, GLICOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAGALHÃES, A et al. Prophylactic and therapeutic vaccination using dendritic cells primed with peptide 10 derived from the 43-kilodalton glycoprotein of Paracoccidioides brasiliensis. Clinical and Vaccine Immunology, v. 19, n. 1, p. 23-29, 2012Tradução . . Acesso em: 02 maio 2024.
APA
Magalhães, A., Ferreira, K. S., Almeida, S. R. de, Nosanchuk, J. D., Travassos, L. R., & Taborda, C. P. (2012). Prophylactic and therapeutic vaccination using dendritic cells primed with peptide 10 derived from the 43-kilodalton glycoprotein of Paracoccidioides brasiliensis. Clinical and Vaccine Immunology, 19( 1), 23-29.
NLM
Magalhães A, Ferreira KS, Almeida SR de, Nosanchuk JD, Travassos LR, Taborda CP. Prophylactic and therapeutic vaccination using dendritic cells primed with peptide 10 derived from the 43-kilodalton glycoprotein of Paracoccidioides brasiliensis. Clinical and Vaccine Immunology. 2012 ; 19( 1): 23-29.[citado 2024 maio 02 ]
Vancouver
Magalhães A, Ferreira KS, Almeida SR de, Nosanchuk JD, Travassos LR, Taborda CP. Prophylactic and therapeutic vaccination using dendritic cells primed with peptide 10 derived from the 43-kilodalton glycoprotein of Paracoccidioides brasiliensis. Clinical and Vaccine Immunology. 2012 ; 19( 1): 23-29.[citado 2024 maio 02 ]
Artigo de periodico
Production of a recombinant dengue virus 2 NS5 protein and potential use as a vaccine antigen (2016)
Alves, Rúbens Prince dos Santos; Pereira, Lennon Ramos; Fabris, Denicar Lina Nascimento; Salvador, Felipe Scassi; Santos, Robert Andreata; Zanotto, Paolo Marinho de Andrade ; Romano, Camila Malta; Amorim, Jaime Henrique; Ferreira, Luís Carlos de Souza
Source: Clinical and Vaccine Immunology. Unidade: ICB
Subjects: VÍRUS DA DENGUE, ANTÍGENOS DE VÍRUS, ANTICORPOS, DENGUE, VACINAS VIRAIS, EPITOPOS, ESCHERICHIA COLI, IMUNOLOGIA CELULAR, PROTEÍNAS RECOMBINANTES, MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Rúbens Prince dos Santos et al. Production of a recombinant dengue virus 2 NS5 protein and potential use as a vaccine antigen. Clinical and Vaccine Immunology, v. 23, n. 6, p. 460-469, 2016Tradução . . Disponível em: https://doi.org/10.1128/CVI.00081-16. Acesso em: 02 maio 2024.
APA
Alves, R. P. dos S., Pereira, L. R., Fabris, D. L. N., Salvador, F. S., Santos, R. A., Zanotto, P. M. de A., et al. (2016). Production of a recombinant dengue virus 2 NS5 protein and potential use as a vaccine antigen. Clinical and Vaccine Immunology, 23( 6), 460-469. doi:10.1128/CVI.00081-16
NLM
Alves RP dos S, Pereira LR, Fabris DLN, Salvador FS, Santos RA, Zanotto PM de A, Romano CM, Amorim JH, Ferreira LC de S. Production of a recombinant dengue virus 2 NS5 protein and potential use as a vaccine antigen [Internet]. Clinical and Vaccine Immunology. 2016 ; 23( 6): 460-469.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/CVI.00081-16
Vancouver
Alves RP dos S, Pereira LR, Fabris DLN, Salvador FS, Santos RA, Zanotto PM de A, Romano CM, Amorim JH, Ferreira LC de S. Production of a recombinant dengue virus 2 NS5 protein and potential use as a vaccine antigen [Internet]. Clinical and Vaccine Immunology. 2016 ; 23( 6): 460-469.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/CVI.00081-16
Artigo de periodico
Pertussis Toxin Improves Immune Responses to a Combined Pneumococcal Antigen and Leads to Enhanced Protection against Streptococcus pneumoniae (2014)
Salcedo-Rivillas, Carolina; Debrie, Anne-Sophie; Miyaji, Eliane Namie; Ferreira Jr., Jorge M. C.; Raw, Isaías; Locht, Camille; Ho, Paulo L.; Mielcarek, Nathalie; Oliveira, Maria Leonor S.
Source: Clinical and Vaccine Immunology. Unidade: FM
Subjects: ANTÍGENOS, VACINAS, STREPTOCOCCUS, TOXINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALCEDO-RIVILLAS, Carolina et al. Pertussis Toxin Improves Immune Responses to a Combined Pneumococcal Antigen and Leads to Enhanced Protection against Streptococcus pneumoniae. Clinical and Vaccine Immunology, v. 21, n. 7, p. 972-981, 2014Tradução . . Disponível em: https://doi.org/10.1128/CVI.00134-14. Acesso em: 02 maio 2024.
APA
Salcedo-Rivillas, C., Debrie, A. -S., Miyaji, E. N., Ferreira Jr., J. M. C., Raw, I., Locht, C., et al. (2014). Pertussis Toxin Improves Immune Responses to a Combined Pneumococcal Antigen and Leads to Enhanced Protection against Streptococcus pneumoniae. Clinical and Vaccine Immunology, 21( 7), 972-981. doi:10.1128/CVI.00134-14
NLM
Salcedo-Rivillas C, Debrie A-S, Miyaji EN, Ferreira Jr. JMC, Raw I, Locht C, Ho PL, Mielcarek N, Oliveira MLS. Pertussis Toxin Improves Immune Responses to a Combined Pneumococcal Antigen and Leads to Enhanced Protection against Streptococcus pneumoniae [Internet]. Clinical and Vaccine Immunology. 2014 ; 21( 7): 972-981.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/CVI.00134-14
Vancouver
Salcedo-Rivillas C, Debrie A-S, Miyaji EN, Ferreira Jr. JMC, Raw I, Locht C, Ho PL, Mielcarek N, Oliveira MLS. Pertussis Toxin Improves Immune Responses to a Combined Pneumococcal Antigen and Leads to Enhanced Protection against Streptococcus pneumoniae [Internet]. Clinical and Vaccine Immunology. 2014 ; 21( 7): 972-981.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/CVI.00134-14
Artigo de periodico
Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life (2016)
Borges, Igor C; Andrade, Dafne C; Cardoso, Maria Regina Alves; Toppari, Jorma; Vähä-Mäkilä, Mari; Ilonen, Jorma; Knip, Mikael; Hyöty, Heikki; Veijola, Riitta; Simell, Olli; Jartti, Tuomas; Käyhty, Helena; Ruuskanen, Olli; Nascimento-Carvalho, Cristiana M.
Source: Clinical and Vaccine Immunology. Unidade: FSP
Subjects: STREPTOCOCCUS PNEUMONIAE, ANTÍGENOS, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Igor C et al. Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life. Clinical and Vaccine Immunology, v. 23, n. 11, p. 878-883, 2016Tradução . . Disponível em: https://doi.org/10.1128/cvi.00341-16. Acesso em: 02 maio 2024.
APA
Borges, I. C., Andrade, D. C., Cardoso, M. R. A., Toppari, J., Vähä-Mäkilä, M., Ilonen, J., et al. (2016). Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life. Clinical and Vaccine Immunology, 23( 11), 878-883. doi:10.1128/cvi.00341-16
NLM
Borges IC, Andrade DC, Cardoso MRA, Toppari J, Vähä-Mäkilä M, Ilonen J, Knip M, Hyöty H, Veijola R, Simell O, Jartti T, Käyhty H, Ruuskanen O, Nascimento-Carvalho CM. Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life [Internet]. Clinical and Vaccine Immunology. 2016 ;23( 11): 878-883.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/cvi.00341-16
Vancouver
Borges IC, Andrade DC, Cardoso MRA, Toppari J, Vähä-Mäkilä M, Ilonen J, Knip M, Hyöty H, Veijola R, Simell O, Jartti T, Käyhty H, Ruuskanen O, Nascimento-Carvalho CM. Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life [Internet]. Clinical and Vaccine Immunology. 2016 ;23( 11): 878-883.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/cvi.00341-16
Artigo de periodico
Increased immunoglobulin G anti-Paracoccidioides brasiliensis serum antibody avidity as a predictor of favorable posttherapeutic evolution in paracoccidioidomycosis (2009)
Yoshida, Márcia; Sanchez, Maria Carmen Arroyo; Shikanai-Yasuda, Maria Aparecida
Source: Clinical and Vaccine Immunology. Unidades: FM, IMT
Subjects: IMUNOGLOBULINAS, ANTICORPOS, PARACOCCIDIOIDES BRASILIENSIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOSHIDA, Márcia e SANCHEZ, Maria Carmen Arroyo e SHIKANAI-YASUDA, Maria Aparecida. Increased immunoglobulin G anti-Paracoccidioides brasiliensis serum antibody avidity as a predictor of favorable posttherapeutic evolution in paracoccidioidomycosis. Clinical and Vaccine Immunology, v. 16, n. 11, p. 1583-1586, 2009Tradução . . Disponível em: http://cdli.asm.org/cgi/reprint/16/11/1583. Acesso em: 02 maio 2024.
APA
Yoshida, M., Sanchez, M. C. A., & Shikanai-Yasuda, M. A. (2009). Increased immunoglobulin G anti-Paracoccidioides brasiliensis serum antibody avidity as a predictor of favorable posttherapeutic evolution in paracoccidioidomycosis. Clinical and Vaccine Immunology, 16( 11), 1583-1586. Recuperado de http://cdli.asm.org/cgi/reprint/16/11/1583
NLM
Yoshida M, Sanchez MCA, Shikanai-Yasuda MA. Increased immunoglobulin G anti-Paracoccidioides brasiliensis serum antibody avidity as a predictor of favorable posttherapeutic evolution in paracoccidioidomycosis [Internet]. Clinical and Vaccine Immunology. 2009 ; 16( 11): 1583-1586.[citado 2024 maio 02 ] Available from: http://cdli.asm.org/cgi/reprint/16/11/1583
Vancouver
Yoshida M, Sanchez MCA, Shikanai-Yasuda MA. Increased immunoglobulin G anti-Paracoccidioides brasiliensis serum antibody avidity as a predictor of favorable posttherapeutic evolution in paracoccidioidomycosis [Internet]. Clinical and Vaccine Immunology. 2009 ; 16( 11): 1583-1586.[citado 2024 maio 02 ] Available from: http://cdli.asm.org/cgi/reprint/16/11/1583
Artigo de periodico
Immunogenicity of whole cell low lipopolysaccharide pertussis vaccine in infants (2009)
Zorzeto, Tatiane Queiroz; Higashi, Hisako Gondo; Silva, Marcos Tadeu Nolasco da; Carniel, Emilia de Faria; Dias, Waldely de Oliveira; Ramalho, Vanessa Domingues; Mazzola, Taís Nitsch; Lima, Simone Corte Batista Souza; Morcillo, André Moreno; Stephano, Marco Antônio ; Antonio, Maria Ângela Reis de Góes; Zanolli, Maria de Lurdes; Raw, Isaias; Vilela, Maria Marluce dos Santos
Source: Clinical and Vaccine Immunology. Unidade: FCF
Subjects: LIPOPOLISSACARÍDEOS, IMUNOGENÉTICA, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZORZETO, Tatiane Queiroz et al. Immunogenicity of whole cell low lipopolysaccharide pertussis vaccine in infants. Clinical and Vaccine Immunology, v. 16, n. 4, p. 544-550, 2009Tradução . . Disponível em: http://cvi.asm.org/cgi/reprint/CVI.00339-08v1. Acesso em: 02 maio 2024.
APA
Zorzeto, T. Q., Higashi, H. G., Silva, M. T. N. da, Carniel, E. de F., Dias, W. de O., Ramalho, V. D., et al. (2009). Immunogenicity of whole cell low lipopolysaccharide pertussis vaccine in infants. Clinical and Vaccine Immunology, 16( 4), 544-550. Recuperado de http://cvi.asm.org/cgi/reprint/CVI.00339-08v1
NLM
Zorzeto TQ, Higashi HG, Silva MTN da, Carniel E de F, Dias W de O, Ramalho VD, Mazzola TN, Lima SCBS, Morcillo AM, Stephano MA, Antonio MÂR de G, Zanolli M de L, Raw I, Vilela MM dos S. Immunogenicity of whole cell low lipopolysaccharide pertussis vaccine in infants [Internet]. Clinical and Vaccine Immunology. 2009 ; 16( 4): 544-550.[citado 2024 maio 02 ] Available from: http://cvi.asm.org/cgi/reprint/CVI.00339-08v1
Vancouver
Zorzeto TQ, Higashi HG, Silva MTN da, Carniel E de F, Dias W de O, Ramalho VD, Mazzola TN, Lima SCBS, Morcillo AM, Stephano MA, Antonio MÂR de G, Zanolli M de L, Raw I, Vilela MM dos S. Immunogenicity of whole cell low lipopolysaccharide pertussis vaccine in infants [Internet]. Clinical and Vaccine Immunology. 2009 ; 16( 4): 544-550.[citado 2024 maio 02 ] Available from: http://cvi.asm.org/cgi/reprint/CVI.00339-08v1
Artigo de periodico
Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica serovar tTyphimurium flagellin (2013)
Leal, Monica Teixeira Andrade; Camacho, Ariane Guglielmi Ariza; Teixeira, Laís Helena; Bargieri, Daniel Youssef ; Soares, Irene da Silva ; Tararam, Cibele Aparecida; Rodrigues, Mauricio Martins
Source: Clinical and Vaccine Immunology. Unidade: FCF
Subjects: MALÁRIA, VACINAS, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Monica Teixeira Andrade et al. Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica serovar tTyphimurium flagellin. Clinical and Vaccine Immunology, v. 20, n. 9, p. 1418-1425, 2013Tradução . . Disponível em: https://doi.org/10.1128/CVI.00312-13. Acesso em: 02 maio 2024.
APA
Leal, M. T. A., Camacho, A. G. A., Teixeira, L. H., Bargieri, D. Y., Soares, I. da S., Tararam, C. A., & Rodrigues, M. M. (2013). Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica serovar tTyphimurium flagellin. Clinical and Vaccine Immunology, 20( 9), 1418-1425. doi:10.1128/CVI.00312-13
NLM
Leal MTA, Camacho AGA, Teixeira LH, Bargieri DY, Soares I da S, Tararam CA, Rodrigues MM. Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica serovar tTyphimurium flagellin [Internet]. Clinical and Vaccine Immunology. 2013 ; 20( 9): 1418-1425.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/CVI.00312-13
Vancouver
Leal MTA, Camacho AGA, Teixeira LH, Bargieri DY, Soares I da S, Tararam CA, Rodrigues MM. Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica serovar tTyphimurium flagellin [Internet]. Clinical and Vaccine Immunology. 2013 ; 20( 9): 1418-1425.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/CVI.00312-13
Artigo de periodico
Evaluation of leptospiral recombinant antigens MPL17 and MPL21 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assays (2008)
Oliveira, Tatiane Rodrigues de; Longhi, M. T; Morais, Zenaide Maria de; Romero, Eliete Caló; Blanco, Roberta Morozetti; Kirchgatter, Karin; Vasconcellos, Silvio Arruda; Nascimento, Ana Lúcia Tabet Oller do
Source: Clinical and Vaccine Immunology. Unidade: FMVZ
Subjects: LEPTOSPIROSE ANIMAL, IMUNIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Tatiane Rodrigues de et al. Evaluation of leptospiral recombinant antigens MPL17 and MPL21 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assays. Clinical and Vaccine Immunology, v. 15, n. 11, p. 1715-1722, 2008Tradução . . Disponível em: https://doi.org/10.1128/CVI.00214-08. Acesso em: 02 maio 2024.
APA
Oliveira, T. R. de, Longhi, M. T., Morais, Z. M. de, Romero, E. C., Blanco, R. M., Kirchgatter, K., et al. (2008). Evaluation of leptospiral recombinant antigens MPL17 and MPL21 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assays. Clinical and Vaccine Immunology, 15( 11), 1715-1722. doi:10.1128/CVI.00214-08
NLM
Oliveira TR de, Longhi MT, Morais ZM de, Romero EC, Blanco RM, Kirchgatter K, Vasconcellos SA, Nascimento ALTO do. Evaluation of leptospiral recombinant antigens MPL17 and MPL21 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assays [Internet]. Clinical and Vaccine Immunology. 2008 ; 15( 11): 1715-1722.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/CVI.00214-08
Vancouver
Oliveira TR de, Longhi MT, Morais ZM de, Romero EC, Blanco RM, Kirchgatter K, Vasconcellos SA, Nascimento ALTO do. Evaluation of leptospiral recombinant antigens MPL17 and MPL21 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assays [Internet]. Clinical and Vaccine Immunology. 2008 ; 15( 11): 1715-1722.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/CVI.00214-08
Artigo de periodico
Evaluation of a Recombinant Trypanosoma cruzi Mucin-Like Antigen for Serodiagnosis of Chagas' Disease (2011)
De Marchi, Claudia R.; Di Noia, Javier M.; Frasch, Alberto C. C.; Amato Neto, Vicente; Almeida, Igor C.; Buscaglia, Carlos A.
Source: Clinical and Vaccine Immunology. Unidade: FM
Subjects: PROTEÍNAS RECOMBINANTES, IMUNOFLUORESCÊNCIA (PARASITOLOGIA;IMUNOLOGIA), DOENÇA DE CHAGAS (DIAGNÓSTICO;PARASITOLOGIA;AVALIAÇÃO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE MARCHI, Claudia R. et al. Evaluation of a Recombinant Trypanosoma cruzi Mucin-Like Antigen for Serodiagnosis of Chagas' Disease. Clinical and Vaccine Immunology, v. 18, n. 11, p. 1850-1855, 2011Tradução . . Disponível em: https://doi.org/10.1128/CVI.05289-11. Acesso em: 02 maio 2024.
APA
De Marchi, C. R., Di Noia, J. M., Frasch, A. C. C., Amato Neto, V., Almeida, I. C., & Buscaglia, C. A. (2011). Evaluation of a Recombinant Trypanosoma cruzi Mucin-Like Antigen for Serodiagnosis of Chagas' Disease. Clinical and Vaccine Immunology, 18( 11), 1850-1855. doi:10.1128/CVI.05289-11
NLM
De Marchi CR, Di Noia JM, Frasch ACC, Amato Neto V, Almeida IC, Buscaglia CA. Evaluation of a Recombinant Trypanosoma cruzi Mucin-Like Antigen for Serodiagnosis of Chagas' Disease [Internet]. Clinical and Vaccine Immunology. 2011 ; 18( 11): 1850-1855.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/CVI.05289-11
Vancouver
De Marchi CR, Di Noia JM, Frasch ACC, Amato Neto V, Almeida IC, Buscaglia CA. Evaluation of a Recombinant Trypanosoma cruzi Mucin-Like Antigen for Serodiagnosis of Chagas' Disease [Internet]. Clinical and Vaccine Immunology. 2011 ; 18( 11): 1850-1855.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/CVI.05289-11
Artigo de periodico
Evaluation of Serological Tests To Identify Trypanosoma cruzi Infection in Humans and Determine Cross-Reactivity with Trypanosoma rangeli and Leishmania spp (2007)
Caballero, Zuleima C.; Sousa, Octavio E.; Marques, Waldelania P.; Saez-Alquezar, Amadeo; Umezawa, Eufrosina S.
Source: Clinical and Vaccine Immunology. Unidade: FM
Subjects: TRYPANOSOMA CRUZI (TESTES;SANGUE), IMUNOENSAIO, DOENÇA DE CHAGAS (DIAGNÓSTICO), LEISHMANIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CABALLERO, Zuleima C. et al. Evaluation of Serological Tests To Identify Trypanosoma cruzi Infection in Humans and Determine Cross-Reactivity with Trypanosoma rangeli and Leishmania spp. Clinical and Vaccine Immunology, v. 14, n. 8, p. 1045-1049, 2007Tradução . . Disponível em: https://doi.org/10.1128/cvi.00127-07. Acesso em: 02 maio 2024.
APA
Caballero, Z. C., Sousa, O. E., Marques, W. P., Saez-Alquezar, A., & Umezawa, E. S. (2007). Evaluation of Serological Tests To Identify Trypanosoma cruzi Infection in Humans and Determine Cross-Reactivity with Trypanosoma rangeli and Leishmania spp. Clinical and Vaccine Immunology, 14( 8), 1045-1049. doi:10.1128/cvi.00127-07
NLM
Caballero ZC, Sousa OE, Marques WP, Saez-Alquezar A, Umezawa ES. Evaluation of Serological Tests To Identify Trypanosoma cruzi Infection in Humans and Determine Cross-Reactivity with Trypanosoma rangeli and Leishmania spp [Internet]. Clinical and Vaccine Immunology. 2007 ; 14( 8): 1045-1049.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/cvi.00127-07
Vancouver
Caballero ZC, Sousa OE, Marques WP, Saez-Alquezar A, Umezawa ES. Evaluation of Serological Tests To Identify Trypanosoma cruzi Infection in Humans and Determine Cross-Reactivity with Trypanosoma rangeli and Leishmania spp [Internet]. Clinical and Vaccine Immunology. 2007 ; 14( 8): 1045-1049.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/cvi.00127-07
Artigo de periodico
Enhancement of Diagnostic Efficiency by a Gamma Interferon Release Assay for Pulmonary Tuberculosis (2008)
Kanunfre, Kelly Aparecida; Leite, Olavo Henrique Munhoz; Lopes, Max Igor; Litvoc, Marcelo; Ferreira, Antonio Walter
Source: Clinical and Vaccine Immunology. Unidade: FM
Subjects: DOENÇAS INFECCIOSAS (DIAGNÓSTICO;TERAPIA), TUBERCULOSE PULMONAR (AVALIAÇÃO;DIAGNÓSTICO), INTERFERONS (USO TERAPÊUTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KANUNFRE, Kelly Aparecida et al. Enhancement of Diagnostic Efficiency by a Gamma Interferon Release Assay for Pulmonary Tuberculosis. Clinical and Vaccine Immunology, v. 15, n. 6, p. 1028-1030, 2008Tradução . . Disponível em: https://doi.org/10.1128/cvi.00026-08. Acesso em: 02 maio 2024.
APA
Kanunfre, K. A., Leite, O. H. M., Lopes, M. I., Litvoc, M., & Ferreira, A. W. (2008). Enhancement of Diagnostic Efficiency by a Gamma Interferon Release Assay for Pulmonary Tuberculosis. Clinical and Vaccine Immunology, 15( 6), 1028-1030. doi:10.1128/cvi.00026-08
NLM
Kanunfre KA, Leite OHM, Lopes MI, Litvoc M, Ferreira AW. Enhancement of Diagnostic Efficiency by a Gamma Interferon Release Assay for Pulmonary Tuberculosis [Internet]. Clinical and Vaccine Immunology. 2008 ; 15( 6): 1028-1030.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/cvi.00026-08
Vancouver
Kanunfre KA, Leite OHM, Lopes MI, Litvoc M, Ferreira AW. Enhancement of Diagnostic Efficiency by a Gamma Interferon Release Assay for Pulmonary Tuberculosis [Internet]. Clinical and Vaccine Immunology. 2008 ; 15( 6): 1028-1030.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/cvi.00026-08
Artigo de periodico
Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration (2011)
Mathias-Santos, Camila; Rodrigues, Juliana Falcão; Sbrogio-Almeida, Maria Elisabete; Connell, Terry D.; Ferreira, Luís Carlos de Souza
Source: Clinical and Vaccine Immunology. Unidade: ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATHIAS-SANTOS, Camila et al. Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration. Clinical and Vaccine Immunology, v. 18, n. 8, p. 1243-1251, 2011Tradução . . Disponível em: https://doi.org/10.1128/CVI.00012-11. Acesso em: 02 maio 2024.
APA
Mathias-Santos, C., Rodrigues, J. F., Sbrogio-Almeida, M. E., Connell, T. D., & Ferreira, L. C. de S. (2011). Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration. Clinical and Vaccine Immunology, 18( 8), 1243-1251. doi:10.1128/CVI.00012-11
NLM
Mathias-Santos C, Rodrigues JF, Sbrogio-Almeida ME, Connell TD, Ferreira LC de S. Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration [Internet]. Clinical and Vaccine Immunology. 2011 ; 18( 8): 1243-1251.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/CVI.00012-11
Vancouver
Mathias-Santos C, Rodrigues JF, Sbrogio-Almeida ME, Connell TD, Ferreira LC de S. Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration [Internet]. Clinical and Vaccine Immunology. 2011 ; 18( 8): 1243-1251.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/CVI.00012-11
Artigo de periodico
Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC (2012)
Moreno, Adriana Tonet; Oliveira, Maria Leonor Sarno de; Ho, Paulo Lee; Vadesilho, Cintia Fiuza Marques; Palma, Giovana M. P; Ferreira Junior, Jorge Mario da Costa; Ferreira, Daniela Mulari; Santos, Silvia Regina Cavani Jorge ; Martinez, Marina Baquerizo; Miyaji, Eliane Namie
Source: Clinical and Vaccine Immunology. Unidade: FCF
Subjects: STREPTOCOCCUS, ANTICORPOS, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENO, Adriana Tonet et al. Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC. Clinical and Vaccine Immunology, v. 19, n. 4, p. 499-507 : + Supplementary materials, 2012Tradução . . Disponível em: https://doi.org/10.1128/cvi-05706-11. Acesso em: 02 maio 2024.
APA
Moreno, A. T., Oliveira, M. L. S. de, Ho, P. L., Vadesilho, C. F. M., Palma, G. M. P., Ferreira Junior, J. M. da C., et al. (2012). Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC. Clinical and Vaccine Immunology, 19( 4), 499-507 : + Supplementary materials. doi:10.1128/cvi-05706-11
NLM
Moreno AT, Oliveira MLS de, Ho PL, Vadesilho CFM, Palma GMP, Ferreira Junior JM da C, Ferreira DM, Santos SRCJ, Martinez MB, Miyaji EN. Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC [Internet]. Clinical and Vaccine Immunology. 2012 ; 19( 4): 499-507 : + Supplementary materials.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/cvi-05706-11
Vancouver
Moreno AT, Oliveira MLS de, Ho PL, Vadesilho CFM, Palma GMP, Ferreira Junior JM da C, Ferreira DM, Santos SRCJ, Martinez MB, Miyaji EN. Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC [Internet]. Clinical and Vaccine Immunology. 2012 ; 19( 4): 499-507 : + Supplementary materials.[citado 2024 maio 02 ] Available from: https://doi.org/10.1128/cvi-05706-11
Artigo de periodico
Compartmentalization of interleukin-6 response in a patient with septic meningococcal peritonitis (2006)
Souza, Alexandre Leite de; Sztajnbok, Jaques; Salgado, Maristela Marques; Romano, Carla C.; Alkmin, Maria das Graças Adelino; Duarte, Alberto José da Silva; Seguro, Antonio Carlos
Source: Clinical and Vaccine Immunology. Unidade: FM
Subjects: INTERLEUCINA 6 (IMUNOLOGIA), MENINGITE VIRAL (DIAGNÓSTICO;CLASSIFICAÇÃO), INFLAMAÇÃO, SEPSE (COMPLICAÇÕES)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Alexandre Leite de et al. Compartmentalization of interleukin-6 response in a patient with septic meningococcal peritonitis. Clinical and Vaccine Immunology, v. 13, n. 11, p. 1287-1290, 2006Tradução . . Acesso em: 02 maio 2024.
APA
Souza, A. L. de, Sztajnbok, J., Salgado, M. M., Romano, C. C., Alkmin, M. das G. A., Duarte, A. J. da S., & Seguro, A. C. (2006). Compartmentalization of interleukin-6 response in a patient with septic meningococcal peritonitis. Clinical and Vaccine Immunology, 13( 11), 1287-1290.
NLM
Souza AL de, Sztajnbok J, Salgado MM, Romano CC, Alkmin M das GA, Duarte AJ da S, Seguro AC. Compartmentalization of interleukin-6 response in a patient with septic meningococcal peritonitis. Clinical and Vaccine Immunology. 2006 ; 13( 11): 1287-1290.[citado 2024 maio 02 ]
Vancouver
Souza AL de, Sztajnbok J, Salgado MM, Romano CC, Alkmin M das GA, Duarte AJ da S, Seguro AC. Compartmentalization of interleukin-6 response in a patient with septic meningococcal peritonitis. Clinical and Vaccine Immunology. 2006 ; 13( 11): 1287-1290.[citado 2024 maio 02 ]

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation